Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

The Deal Names Catherine Dargan a 2020 Dealmaker of the Year

September 25, 2020

WASHINGTON—The Deal recognized Catherine Dargan as its Healthcare, Pharma & Biotech Dealmaker of the Year at its annual “Deal Awards.”

Ms. Dargan has advised numerous companies on their important strategic transactions for over 20 years. She has broad experience in mergers and acquisitions, both public and private (domestically and cross-border), and partnering arrangements, and counsels clients regularly on corporate governance and compliance matters. She regularly advises clients on a variety of commercial agreements relating to manufacturing, supply, and distribution of core products, and represents clients in a variety of industries including life sciences, education, defense and government contracting, consumer products, technology and gaming, media, and industrials. Representative life sciences clients include, among others, Astellas, AstraZeneca, Boehringer Ingelheim, Eisai, Elanco, Emergent BioSolutions, and Merck.

The “Deal Awards,” announced September 25, recognizes the leading lawyers, bankers, and advisors shaping the deal economy. Honorees were selected based on peer nominations and interviews with analysts and experts.

Share this article: